(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 31.18% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.47%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Personalis's revenue in 2026 is $69,648,000.On average, 9 Wall Street analysts forecast PSNL's revenue for 2026 to be $8,405,388,960, with the lowest PSNL revenue forecast at $7,998,057,238, and the highest PSNL revenue forecast at $8,690,196,807. On average, 9 Wall Street analysts forecast PSNL's revenue for 2027 to be $11,890,361,388, with the lowest PSNL revenue forecast at $10,192,396,019, and the highest PSNL revenue forecast at $12,997,366,171.
In 2028, PSNL is forecast to generate $16,934,662,009 in revenue, with the lowest revenue forecast at $14,949,796,156 and the highest revenue forecast at $18,847,331,898.